The single strand conformation polymorphism (SSCP) technique was used to screen genomlc DMA of a family with myotonia aggravated by cold, potassium loading and suxamethonlum, but without muscle weakness. An aberrant band was found In exon 24 of SCN4A, the gene encoding the adult skeletal muscle sodium channel a-subunK. DNA sequencing led to the detection of a G-to-A transition of cDNA nucleotlde 4765 predicting a substitution of methlonlne for vallne at position 1589 of the protein sequence. This amlno acid Is located within transmembrane segment S6 of channel repeat IV dose to the cytoplasmlc surface, a region which is supposed to act as acceptor of the Inactivatlon gate of the channel. Four lines of evidence Indicate that this mutation causes the disease: (I) the transition was only found for affected family members; (II) no mutations were found In all other SCN4A exons; (HI) the affected gene region Is conserved among various species; and (Iv) an .Increase In the number of non-lnactlvatlng sodium channels had been revealed In earlier electrophyslologlcal studies on an excised muscle specimen from the Index patient. In addition, the dose-by occurring substitution of vallne for methlonlne at position 1592 known to cause hyperkalemic periodic paralysis was deduced for six families with the myotonte, non-dystrophlc form of this disease.
INTRODUCTION
Different mutations in SCN4A, the gene encoding the adult skeletal muscle sodium channel a-subunit have been shown to cause the human hereditary disorders hyperkalemic periodic paralysis and paramyotonia congcnita. 1 
"
8 As a consequence, the long-standing question as to whether these two diseases are directly related was finally settled: thus the term 'sodium channel disease ' 7 was introduced to encompass the different allelic syndromes caused by SCN4A gene mutations.
According to this definition, muscle sodium channel diseases encompass: i) classical paramyotonia congenha (PC) as characterized by the key symptoms of paradoxical myotonia (muscle stiffness aggravated by exercise) and cold-induced muscle stiffness followed by weakness, 9 ' 10 and its variants such as: PC with myotonic signs present even in a warm environment; PC without weakness, not even during strenuous exertion of the cooled muscles; and PC with spontaneous and potassium-induced attacks of weakness; ii) hyperkalemic periodic paralysis (HyperPP) characterized by the symptoms of spontaneous and potassium-induced attacks of weakness 11 and associated with or without myotonia or paramyotoni. 12 The relationship between these diseases and another condition characterized by muscle stiffness responsive to acetazolamide, 13 a potassium-lowering drug, has not been clarified.
We recently classified a third group of muscle sodium channel diseases, namely sodium channel myotonia. 14 This disease is characterized by a dominant mode of inheritance, and has as its key symptom muscle stiffness without muscle weakness. Moreover, in the families examined die stiffness was not substantially aggravated by cold. In some of them myotonia is mild and considerably variable from day to day (myotonia fluctuans 15 -8 ). In other families the myotonia is very severe and continually present (permanent myotonia 8 ). The molecular biological findings of different defects in the . gene encoding the muscle sodium channel had been anticipated by electrophysiological studies on excised muscle specimens from such patients. Experiments on native muscle fiber segments performed with the three-microekctrode voltage clamp and, later, also with patch-clamp methods have revealed that the sodium currents underlying the repetitive firing of muscle fiber action potentials show a peculiar failure to inactivate properly.
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In the present study we investigate the genetic defect in a family with dominant myotonia for which an earlier electrophysiologic study had revealed abnormal sodium currents. 19 Based on the dominant inheritance and the clinical signs we had then misdiagnosed the disease as myotonia congenita (Thomsen), a disease now known to be caused by a defect in the muscle chloride channel. 20 Now we are able to show that the symptoms are caused by a previously unidentified mutation in SCN4A, and thus provide further evidence for the existence of sodium channel myotonia. Some of the data were presented at the 17th ENMC Workshop on 'Non-dystrophic myotonias and periodic paralyses 1 .
RESULTS
Abnormalities in the mobility of single-strand DNA fragments of the SCN4A transcript were found for several members of family SCM8. All abnormalities were detected in the region of exon 24 which encodes the transmembrane segment S6 of repeat IV. For the affected family members, the index patient and his affected daughter, a peculiar aberrant band (A in Figure 1 ) was discovered which was not present in the DNA of the parents, the brothers and the son of the index patient. A second aberrant band was found for the daughter (Figure 1, band B) . This band was also found for her mother and several other non-affected family members and also for a normal control. In the same exon, an aberrant band different from the two former ones was detected in six out of 25 HyperPP families (two examples in Figure 1 , band Q. No exon 24 abnormalities were detected for 76 normal controls. For the index patient and his daughter, no abnormal polymorphisms were detected in exons 1 -23. For some normal controls, aberrant bands were found in exons previously described and, in addition, in exons 3 and 10 (not shown).
By sequencing the DNA eluted from the aberrant band (A) which was found for the index patient and his daughter, a G-to-A transition at position 4765 of the adult skeletal muscle sodium channel a-subunit cDNA was discovered, predicting a substitution of methionine for valine-1589 ( Figure 2) ; no mutation was found in exons 1 -23 of the genomic DNA from the index patient. The aberrant band (B) found for the index patient's daughter and her mother was caused by a C/A polymorphism at cDNA nucleotide 4536 which has no effect on the amino acid. For the affected members of the six families with HyperPP, a previously described A-to-G transition at position 4774 was detected, predicting the substitution of valine for methionine-1592 ( Figure 1 The condition characterized by muscle stiffness responsive to acetazolamide may also belong to this group since linkage to the SCN4A gene has been reported. 13 Obviously, the symptoms of sodium channel myotonia overlap considerably with those of chloride channel myotonia, and for an unexperienced examiner clinical differentiation may be impossible. We expect that more diagnoses of 'dominant myotonia congenita' will have to be converted to sodium channel myotonia after molecular biological investigations similar to the present study have been performed.
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The symptoms of sodium channel myotonia also overlap with those of PC. For all PC families that were studied with molecular biological methods, point mutations were detected in distinct regions of SCN4A: (i) a C3938T transition causing a substitution of threonine for methionine-1313 was discovered in the gene fragment encoding the cytoplasmic loop between repeats m and IV, the putative inactivation gate; 4 -23 (ii) two mutations at the adjacent nucleotide sites 4342/4343 were detected in a gene region encoding the transmembrane segment S4 of repeat IV; 3 (iii) another point mutation was discovered in the transmembrane segment S3 of repeat IV. The transversion T4298G predicts the amino acid substitute arginine for leucine at position 1433 located in segment S3 of repeat IV. 6 The novel G476SA transition causing sodium channel myotonia predicts the substitution of methionine for valine-1589 in segment S6 of repeat IV. It is located right next to die helical position of the inverse substitution for memkmine-1592 that causes hyperkalemic periodic paralysis.
1 Both substitutions have in common i) that they affect highly conserved amino acids, ii) that the amino acids both are close to the cytoplasmic surface and iii) that both induce an increase in the number of non-inactivating sodium channels.
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- 23 This result indicates that this region of the channel is important for normal fast inactivation of the sodium channel and lends support to the view that it is this region that acts as die acceptor of die inactivation gate. 26 Not surprisingly, both mutations are associated with potassium sensitivity (potassium-induced weakness in the met-to-val substitution; potassium-induced stiffness in the val-to-met substitution). The difference between die two phenotypes, weakness versus stiffness, could be due to a different degree of sustained membrane depolarization resulting from die disturbed sodium channel inactivation: slight sustained depolarization to potentials at which die muscle fiber is still hyperexcitable (stiffness); or larger sustained depolarization to values at which most of the genetically normal sodium channels are already inactivated and the membrane is therefore inexcitable (weakness). 8 The second difference pertains to the temperature sensitivity which is only found for die mutation at die 1589 location.
It must be admitted, however, that die clinical phenotypes of sodium channel myotonia and hyperkalemic periodic paralysis are so different that we must discuss the possibility that die described mutation is not responsible for die disease. In particular die fact that several SCN4A polymorphisms have been detected makes this alternative possible: including the two polymorphisms discovered in this study, eight polymorphisms causing 'benign' amino acid substitutions are now known (reviewed by 14 ). On die other hand, several arguments support our contention that it is die described point mutation that causes die disease: (i) die G4765A transition was only found in die DNA of die two affected family members; (ii) no otiier SCN4A mutation was detected for these two patients; (iii) the affected gene region is highly conserved; and (iv) die mutation is associated wim disturbed sodium channel inactivation as reported earlier from electrophysiological studies performed on an excised muscle specimen obtained from die index patient of diis family.
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MATERIALS AND METHODS
Patients
The family pedigree is shown in Figure 1 (SCM8) . In a study performed at a time when SCN4A had not yet been located, the family was Hi«gnn««H as having autosomal dominant myotonia congenita with aggravation of myotoma in cold environment and by potassium load." The index patient (who had given informed consent for a thorough clinical and genetic investigation as well as for a vastus medialis muscle biopsy) was consequently labeled as myotonia cougeuila patient 2 (MyC2). This ^^ng'^t^f is now corrected to n^iylf sodium ?hf mifl myotonia (SCM) aggravated in cold, by potassium and suxamethomum.
History. In 1986, the index patient (then at the age of 32 years) had a generalized niyotonic reaction and imMirliial i[miim after flnhijiiMin of general anaesthesia with thiopental and suxametnonium (100 mg; the drug is known to aggravate myotomc reaction).
CtbtlcalftntBngr. At room temperature, the elbow flexor and die elbow and knee extensor muscles were able to produce normal force, but the knee flexor muscles showed initial weakness mat gradually disappeared with repetitive activity. The tid lag plwMiienon was present and aggravated by repetitive closure and opduiig of die eyes. Percussion myotonia was elicitable in almost all m»«<-b-Grip myotonia was present, gliglily after rest and becoming better with repetitive movements (warm-up phenomenon), but increased after strenuous work. Muscle mass was normal except for a slight atrophy of die right pectoralis major muscle, perhaps as part of a C-7 syndrome. Myotonic cataract was deluded. 
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Direct PCR sequencing: Single SSCP bands were cut direcdy from the gel under UV light and placed for 1 h in 100 pi of distilled water at 37'C. A 10 pi aliquot was used for PCR amplification with 5' extended universal primers as described by PufCek and co-workers. 3 Amplified products were resolved on a 3% agarose gd and isolated from the gd with Qiaex (Diagen, DQtsddorf, Germany). Samples were irqnenced with the dideoxy termination method using Taq poh/merase, M13 universal and reverse sequencing primers, and fhiorescently tagged 
